nodes	percent_of_prediction	percent_of_DWPC	metapath
Valaciclovir—Nucleoside Analog—Azathioprine—Crohn's disease	0.833	1	CiPCiCtD
Valaciclovir—SLC22A8—Mercaptopurine—Crohn's disease	0.063	1	CbGbCtD
Valaciclovir—SLC10A2—bile—Crohn's disease	0.0211	0.667	CbGeAlD
Valaciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—CPEB4—Crohn's disease	0.0048	0.187	CbGpPWpGaD
Valaciclovir—SLC6A14—digestive system—Crohn's disease	0.00355	0.112	CbGeAlD
Valaciclovir—SLC10A2—digestive system—Crohn's disease	0.00231	0.0729	CbGeAlD
Valaciclovir—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A5—Crohn's disease	0.00183	0.0714	CbGpPWpGaD
Valaciclovir—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A4—Crohn's disease	0.00183	0.0714	CbGpPWpGaD
Valaciclovir—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A5—Crohn's disease	0.00153	0.0596	CbGpPWpGaD
Valaciclovir—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A4—Crohn's disease	0.00153	0.0596	CbGpPWpGaD
Valaciclovir—SLC15A2—mouth—Crohn's disease	0.00126	0.0399	CbGeAlD
Valaciclovir—SLC15A1—epithelium—Crohn's disease	0.00118	0.0372	CbGeAlD
Valaciclovir—Rectal disorder—Mesalazine—Crohn's disease	0.00104	0.0224	CcSEcCtD
Valaciclovir—SLC15A1—mammalian vulva—Crohn's disease	0.00102	0.0322	CbGeAlD
Valaciclovir—SLC10A2—Recycling of bile acids and salts—ALB—Crohn's disease	0.000975	0.038	CbGpPWpGaD
Valaciclovir—Anorectal disorder—Mesalazine—Crohn's disease	0.000967	0.0209	CcSEcCtD
Valaciclovir—SLC6A14—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.000941	0.0367	CbGpPWpGaD
Valaciclovir—SLC6A14—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.000941	0.0367	CbGpPWpGaD
Valaciclovir—SLC15A1—digestive system—Crohn's disease	0.000895	0.0283	CbGeAlD
Valaciclovir—Platelet count decreased—Mesalazine—Crohn's disease	0.000855	0.0185	CcSEcCtD
Valaciclovir—Mouth ulceration—Mercaptopurine—Crohn's disease	0.000847	0.0183	CcSEcCtD
Valaciclovir—Menorrhagia—Mesalazine—Crohn's disease	0.000687	0.0148	CcSEcCtD
Valaciclovir—Rhinorrhoea—Mesalazine—Crohn's disease	0.000628	0.0136	CcSEcCtD
Valaciclovir—Acne—Mesalazine—Crohn's disease	0.000604	0.013	CcSEcCtD
Valaciclovir—SLC6A14—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.000586	0.0228	CbGpPWpGaD
Valaciclovir—Dysmenorrhoea—Mesalazine—Crohn's disease	0.000559	0.0121	CcSEcCtD
Valaciclovir—Cough increased—Mesalazine—Crohn's disease	0.000555	0.012	CcSEcCtD
Valaciclovir—Aplastic anaemia—Azathioprine—Crohn's disease	0.000524	0.0113	CcSEcCtD
Valaciclovir—Stomatitis—Mercaptopurine—Crohn's disease	0.000511	0.011	CcSEcCtD
Valaciclovir—SLC10A2—Bile acid and bile salt metabolism—ALB—Crohn's disease	0.00051	0.0199	CbGpPWpGaD
Valaciclovir—Phosphatase alkaline increased—Mesalazine—Crohn's disease	0.000508	0.011	CcSEcCtD
Valaciclovir—Hepatobiliary disease—Mercaptopurine—Crohn's disease	0.000496	0.0107	CcSEcCtD
Valaciclovir—Aplastic anaemia—Mesalazine—Crohn's disease	0.000477	0.0103	CcSEcCtD
Valaciclovir—Coma—Mesalazine—Crohn's disease	0.000465	0.01	CcSEcCtD
Valaciclovir—Mouth ulceration—Mesalazine—Crohn's disease	0.00046	0.00993	CcSEcCtD
Valaciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000427	0.0167	CbGpPWpGaD
Valaciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000427	0.0167	CbGpPWpGaD
Valaciclovir—Immune system disorder—Mercaptopurine—Crohn's disease	0.000425	0.00918	CcSEcCtD
Valaciclovir—Blood alkaline phosphatase increased—Mesalazine—Crohn's disease	0.000424	0.00916	CcSEcCtD
Valaciclovir—Photosensitivity—Mesalazine—Crohn's disease	0.00042	0.00908	CcSEcCtD
Valaciclovir—Alopecia—Mercaptopurine—Crohn's disease	0.000416	0.00898	CcSEcCtD
Valaciclovir—Eczema—Mesalazine—Crohn's disease	0.000411	0.00887	CcSEcCtD
Valaciclovir—Renal failure acute—Mesalazine—Crohn's disease	0.0004	0.00863	CcSEcCtD
Valaciclovir—Renal impairment—Mesalazine—Crohn's disease	0.000388	0.00837	CcSEcCtD
Valaciclovir—Anaemia—Mercaptopurine—Crohn's disease	0.000378	0.00817	CcSEcCtD
Valaciclovir—Mania—Prednisone—Crohn's disease	0.00037	0.00799	CcSEcCtD
Valaciclovir—Osteoarthritis—Mesalazine—Crohn's disease	0.000369	0.00797	CcSEcCtD
Valaciclovir—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.000367	0.0143	CbGpPWpGaD
Valaciclovir—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.000367	0.0143	CbGpPWpGaD
Valaciclovir—Leukopenia—Mercaptopurine—Crohn's disease	0.000367	0.00792	CcSEcCtD
Valaciclovir—Migraine—Mesalazine—Crohn's disease	0.000363	0.00785	CcSEcCtD
Valaciclovir—Face oedema—Mesalazine—Crohn's disease	0.000356	0.00769	CcSEcCtD
Valaciclovir—Arthralgia—Mercaptopurine—Crohn's disease	0.000349	0.00753	CcSEcCtD
Valaciclovir—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.000346	0.00748	CcSEcCtD
Valaciclovir—Blood creatinine increased—Mesalazine—Crohn's disease	0.000346	0.00747	CcSEcCtD
Valaciclovir—Liver function test abnormal—Mesalazine—Crohn's disease	0.000341	0.00736	CcSEcCtD
Valaciclovir—Abdominal discomfort—Azathioprine—Crohn's disease	0.000336	0.00725	CcSEcCtD
Valaciclovir—Oedema—Mercaptopurine—Crohn's disease	0.000334	0.00722	CcSEcCtD
Valaciclovir—Aspartate aminotransferase increased—Mesalazine—Crohn's disease	0.000332	0.00718	CcSEcCtD
Valaciclovir—Nasopharyngitis—Mesalazine—Crohn's disease	0.00033	0.00713	CcSEcCtD
Valaciclovir—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.000327	0.00707	CcSEcCtD
Valaciclovir—Alanine aminotransferase increased—Mesalazine—Crohn's disease	0.000325	0.00703	CcSEcCtD
Valaciclovir—Skin disorder—Mercaptopurine—Crohn's disease	0.000325	0.00701	CcSEcCtD
Valaciclovir—Acne—Prednisone—Crohn's disease	0.00032	0.0069	CcSEcCtD
Valaciclovir—SLC15A2—lymph node—Crohn's disease	0.00032	0.0101	CbGeAlD
Valaciclovir—Influenza—Mesalazine—Crohn's disease	0.000319	0.00689	CcSEcCtD
Valaciclovir—Anorexia—Mercaptopurine—Crohn's disease	0.000319	0.00688	CcSEcCtD
Valaciclovir—Bronchitis—Mesalazine—Crohn's disease	0.000307	0.00662	CcSEcCtD
Valaciclovir—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.000306	0.0119	CbGpPWpGaD
Valaciclovir—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.000306	0.0119	CbGpPWpGaD
Valaciclovir—Abdominal discomfort—Mesalazine—Crohn's disease	0.000306	0.0066	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.000304	0.00658	CcSEcCtD
Valaciclovir—SLC6A14—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000301	0.0117	CbGpPWpGaD
Valaciclovir—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.000296	0.0064	CcSEcCtD
Valaciclovir—Hepatobiliary disease—Azathioprine—Crohn's disease	0.000295	0.00638	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000294	0.0114	CbGpPWpGaD
Valaciclovir—Photosensitivity reaction—Mesalazine—Crohn's disease	0.000291	0.00629	CcSEcCtD
Valaciclovir—Decreased appetite—Mercaptopurine—Crohn's disease	0.000291	0.00627	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.000289	0.00623	CcSEcCtD
Valaciclovir—Depression—Mesalazine—Crohn's disease	0.000284	0.00612	CcSEcCtD
Valaciclovir—Renal failure—Mesalazine—Crohn's disease	0.00028	0.00604	CcSEcCtD
Valaciclovir—Stomatitis—Mesalazine—Crohn's disease	0.000277	0.00599	CcSEcCtD
Valaciclovir—Urinary tract infection—Mesalazine—Crohn's disease	0.000276	0.00597	CcSEcCtD
Valaciclovir—Haematuria—Mesalazine—Crohn's disease	0.000271	0.00586	CcSEcCtD
Valaciclovir—Hepatobiliary disease—Mesalazine—Crohn's disease	0.000269	0.00581	CcSEcCtD
Valaciclovir—Sinusitis—Mesalazine—Crohn's disease	0.000267	0.00576	CcSEcCtD
Valaciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000266	0.0104	CbGpPWpGaD
Valaciclovir—Erythema multiforme—Azathioprine—Crohn's disease	0.000265	0.00572	CcSEcCtD
Valaciclovir—Body temperature increased—Mercaptopurine—Crohn's disease	0.000264	0.00571	CcSEcCtD
Valaciclovir—Rhinitis—Mesalazine—Crohn's disease	0.000256	0.00553	CcSEcCtD
Valaciclovir—Hepatitis—Mesalazine—Crohn's disease	0.000255	0.00551	CcSEcCtD
Valaciclovir—Pharyngitis—Mesalazine—Crohn's disease	0.000253	0.00547	CcSEcCtD
Valaciclovir—Immune system disorder—Azathioprine—Crohn's disease	0.000253	0.00547	CcSEcCtD
Valaciclovir—Mediastinal disorder—Azathioprine—Crohn's disease	0.000253	0.00546	CcSEcCtD
Valaciclovir—Urinary tract disorder—Mesalazine—Crohn's disease	0.000252	0.00545	CcSEcCtD
Valaciclovir—Oedema peripheral—Mesalazine—Crohn's disease	0.000252	0.00543	CcSEcCtD
Valaciclovir—Chills—Azathioprine—Crohn's disease	0.000251	0.00543	CcSEcCtD
Valaciclovir—Urethral disorder—Mesalazine—Crohn's disease	0.00025	0.00541	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.00025	0.00973	CbGpPWpGaD
Valaciclovir—Alopecia—Azathioprine—Crohn's disease	0.000248	0.00535	CcSEcCtD
Valaciclovir—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000246	0.00532	CcSEcCtD
Valaciclovir—Erythema multiforme—Mesalazine—Crohn's disease	0.000241	0.00521	CcSEcCtD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000237	0.00925	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000237	0.00925	CbGpPWpGaD
Valaciclovir—Immune system disorder—Mesalazine—Crohn's disease	0.000231	0.00498	CcSEcCtD
Valaciclovir—Mediastinal disorder—Mesalazine—Crohn's disease	0.00023	0.00497	CcSEcCtD
Valaciclovir—Chills—Mesalazine—Crohn's disease	0.000229	0.00495	CcSEcCtD
Valaciclovir—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.000229	0.00891	CbGpPWpGaD
Valaciclovir—Diarrhoea—Mercaptopurine—Crohn's disease	0.000229	0.00494	CcSEcCtD
Valaciclovir—Alopecia—Mesalazine—Crohn's disease	0.000226	0.00487	CcSEcCtD
Valaciclovir—Anaemia—Azathioprine—Crohn's disease	0.000226	0.00487	CcSEcCtD
Valaciclovir—Flatulence—Mesalazine—Crohn's disease	0.000219	0.00473	CcSEcCtD
Valaciclovir—Leukopenia—Azathioprine—Crohn's disease	0.000218	0.00472	CcSEcCtD
Valaciclovir—Tension—Mesalazine—Crohn's disease	0.000218	0.00471	CcSEcCtD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000217	0.00846	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000217	0.00846	CbGpPWpGaD
Valaciclovir—Nervousness—Mesalazine—Crohn's disease	0.000216	0.00466	CcSEcCtD
Valaciclovir—Back pain—Mesalazine—Crohn's disease	0.000215	0.00464	CcSEcCtD
Valaciclovir—Vomiting—Mercaptopurine—Crohn's disease	0.000212	0.00459	CcSEcCtD
Valaciclovir—Injury—Prednisone—Crohn's disease	0.000212	0.00459	CcSEcCtD
Valaciclovir—Rash—Mercaptopurine—Crohn's disease	0.000211	0.00455	CcSEcCtD
Valaciclovir—Dermatitis—Mercaptopurine—Crohn's disease	0.000211	0.00455	CcSEcCtD
Valaciclovir—Tremor—Mesalazine—Crohn's disease	0.000208	0.0045	CcSEcCtD
Valaciclovir—Arthralgia—Azathioprine—Crohn's disease	0.000208	0.00449	CcSEcCtD
Valaciclovir—Myalgia—Azathioprine—Crohn's disease	0.000208	0.00449	CcSEcCtD
Valaciclovir—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.000206	0.00446	CcSEcCtD
Valaciclovir—Anaemia—Mesalazine—Crohn's disease	0.000205	0.00444	CcSEcCtD
Valaciclovir—Angioedema—Mesalazine—Crohn's disease	0.000203	0.00439	CcSEcCtD
Valaciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000202	0.00788	CbGpPWpGaD
Valaciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000202	0.00788	CbGpPWpGaD
Valaciclovir—Leukopenia—Mesalazine—Crohn's disease	0.000199	0.0043	CcSEcCtD
Valaciclovir—Nausea—Mercaptopurine—Crohn's disease	0.000199	0.00429	CcSEcCtD
Valaciclovir—Infection—Azathioprine—Crohn's disease	0.000198	0.00427	CcSEcCtD
Valaciclovir—Osteoarthritis—Prednisone—Crohn's disease	0.000195	0.00422	CcSEcCtD
Valaciclovir—Thrombocytopenia—Azathioprine—Crohn's disease	0.000195	0.00421	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.000195	0.00758	CbGpPWpGaD
Valaciclovir—Cough—Mesalazine—Crohn's disease	0.000194	0.00419	CcSEcCtD
Valaciclovir—Skin disorder—Azathioprine—Crohn's disease	0.000193	0.00418	CcSEcCtD
Valaciclovir—Hypertension—Mesalazine—Crohn's disease	0.000192	0.00414	CcSEcCtD
Valaciclovir—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.000191	0.00744	CbGpPWpGaD
Valaciclovir—Psychotic disorder—Prednisone—Crohn's disease	0.000191	0.00412	CcSEcCtD
Valaciclovir—Myalgia—Mesalazine—Crohn's disease	0.000189	0.00409	CcSEcCtD
Valaciclovir—Arthralgia—Mesalazine—Crohn's disease	0.000189	0.00409	CcSEcCtD
Valaciclovir—Chest pain—Mesalazine—Crohn's disease	0.000189	0.00409	CcSEcCtD
Valaciclovir—Face oedema—Prednisone—Crohn's disease	0.000189	0.00407	CcSEcCtD
Valaciclovir—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.000188	0.00406	CcSEcCtD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000188	0.00731	CbGpPWpGaD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000188	0.00731	CbGpPWpGaD
Valaciclovir—Dry mouth—Mesalazine—Crohn's disease	0.000185	0.004	CcSEcCtD
Valaciclovir—Confusional state—Mesalazine—Crohn's disease	0.000183	0.00395	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.000182	0.0071	CbGpPWpGaD
Valaciclovir—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000181	0.00392	CcSEcCtD
Valaciclovir—Anaphylactic shock—Mesalazine—Crohn's disease	0.000181	0.00392	CcSEcCtD
Valaciclovir—Oedema—Mesalazine—Crohn's disease	0.000181	0.00392	CcSEcCtD
Valaciclovir—Infection—Mesalazine—Crohn's disease	0.00018	0.00389	CcSEcCtD
Valaciclovir—Nervous system disorder—Mesalazine—Crohn's disease	0.000178	0.00384	CcSEcCtD
Valaciclovir—Thrombocytopenia—Mesalazine—Crohn's disease	0.000178	0.00384	CcSEcCtD
Valaciclovir—Tachycardia—Mesalazine—Crohn's disease	0.000177	0.00382	CcSEcCtD
Valaciclovir—Skin disorder—Mesalazine—Crohn's disease	0.000176	0.00381	CcSEcCtD
Valaciclovir—Anorexia—Mesalazine—Crohn's disease	0.000173	0.00373	CcSEcCtD
Valaciclovir—Alanine aminotransferase increased—Prednisone—Crohn's disease	0.000172	0.00372	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000172	0.00371	CcSEcCtD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000167	0.00652	CbGpPWpGaD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000167	0.0065	CbGpPWpGaD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000167	0.0065	CbGpPWpGaD
Valaciclovir—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000165	0.00357	CcSEcCtD
Valaciclovir—Feeling abnormal—Azathioprine—Crohn's disease	0.000164	0.00354	CcSEcCtD
Valaciclovir—Insomnia—Mesalazine—Crohn's disease	0.000164	0.00354	CcSEcCtD
Valaciclovir—Paraesthesia—Mesalazine—Crohn's disease	0.000163	0.00352	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000163	0.00352	CcSEcCtD
Valaciclovir—Dyspnoea—Mesalazine—Crohn's disease	0.000162	0.00349	CcSEcCtD
Valaciclovir—Somnolence—Mesalazine—Crohn's disease	0.000161	0.00348	CcSEcCtD
Valaciclovir—Dyspepsia—Mesalazine—Crohn's disease	0.00016	0.00345	CcSEcCtD
Valaciclovir—Decreased appetite—Mesalazine—Crohn's disease	0.000158	0.00341	CcSEcCtD
Valaciclovir—Abdominal pain—Azathioprine—Crohn's disease	0.000157	0.0034	CcSEcCtD
Valaciclovir—Body temperature increased—Azathioprine—Crohn's disease	0.000157	0.0034	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000157	0.00338	CcSEcCtD
Valaciclovir—Fatigue—Mesalazine—Crohn's disease	0.000156	0.00338	CcSEcCtD
Valaciclovir—Pain—Mesalazine—Crohn's disease	0.000155	0.00335	CcSEcCtD
Valaciclovir—Constipation—Mesalazine—Crohn's disease	0.000155	0.00335	CcSEcCtD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000153	0.00596	CbGpPWpGaD
Valaciclovir—Depression—Prednisone—Crohn's disease	0.00015	0.00324	CcSEcCtD
Valaciclovir—Feeling abnormal—Mesalazine—Crohn's disease	0.000149	0.00323	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000148	0.0032	CcSEcCtD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000148	0.00576	CbGpPWpGaD
Valaciclovir—Hypersensitivity—Azathioprine—Crohn's disease	0.000147	0.00317	CcSEcCtD
Valaciclovir—Urticaria—Mesalazine—Crohn's disease	0.000144	0.00311	CcSEcCtD
Valaciclovir—Body temperature increased—Mesalazine—Crohn's disease	0.000143	0.0031	CcSEcCtD
Valaciclovir—Abdominal pain—Mesalazine—Crohn's disease	0.000143	0.0031	CcSEcCtD
Valaciclovir—SLC15A2—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000142	0.00555	CbGpPWpGaD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000139	0.00543	CbGpPWpGaD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000139	0.00543	CbGpPWpGaD
Valaciclovir—Diarrhoea—Azathioprine—Crohn's disease	0.000136	0.00294	CcSEcCtD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000135	0.00527	CbGpPWpGaD
Valaciclovir—Hallucination—Prednisone—Crohn's disease	0.000134	0.0029	CcSEcCtD
Valaciclovir—Hypersensitivity—Mesalazine—Crohn's disease	0.000134	0.00289	CcSEcCtD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000132	0.00515	CbGpPWpGaD
Valaciclovir—Dizziness—Azathioprine—Crohn's disease	0.000132	0.00284	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—PLA2G4F—Crohn's disease	0.000131	0.0051	CbGpPWpGaD
Valaciclovir—Asthenia—Mesalazine—Crohn's disease	0.00013	0.00281	CcSEcCtD
Valaciclovir—Pruritus—Mesalazine—Crohn's disease	0.000128	0.00277	CcSEcCtD
Valaciclovir—Vomiting—Azathioprine—Crohn's disease	0.000127	0.00273	CcSEcCtD
Valaciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000126	0.00491	CbGpPWpGaD
Valaciclovir—Rash—Azathioprine—Crohn's disease	0.000126	0.00271	CcSEcCtD
Valaciclovir—Dermatitis—Azathioprine—Crohn's disease	0.000125	0.00271	CcSEcCtD
Valaciclovir—Headache—Azathioprine—Crohn's disease	0.000125	0.00269	CcSEcCtD
Valaciclovir—Diarrhoea—Mesalazine—Crohn's disease	0.000124	0.00268	CcSEcCtD
Valaciclovir—Immune system disorder—Prednisone—Crohn's disease	0.000122	0.00264	CcSEcCtD
Valaciclovir—Dizziness—Mesalazine—Crohn's disease	0.00012	0.00259	CcSEcCtD
Valaciclovir—Alopecia—Prednisone—Crohn's disease	0.000119	0.00258	CcSEcCtD
Valaciclovir—Nausea—Azathioprine—Crohn's disease	0.000118	0.00255	CcSEcCtD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000118	0.00458	CbGpPWpGaD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000117	0.00455	CbGpPWpGaD
Valaciclovir—Vomiting—Mesalazine—Crohn's disease	0.000115	0.00249	CcSEcCtD
Valaciclovir—Rash—Mesalazine—Crohn's disease	0.000114	0.00247	CcSEcCtD
Valaciclovir—Dermatitis—Mesalazine—Crohn's disease	0.000114	0.00247	CcSEcCtD
Valaciclovir—Headache—Mesalazine—Crohn's disease	0.000114	0.00245	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—MTMR3—Crohn's disease	0.000111	0.00433	CbGpPWpGaD
Valaciclovir—Anaemia—Prednisone—Crohn's disease	0.000109	0.00235	CcSEcCtD
Valaciclovir—Agitation—Prednisone—Crohn's disease	0.000108	0.00233	CcSEcCtD
Valaciclovir—Nausea—Mesalazine—Crohn's disease	0.000108	0.00233	CcSEcCtD
Valaciclovir—Angioedema—Prednisone—Crohn's disease	0.000107	0.00232	CcSEcCtD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000104	0.00405	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000103	0.004	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000103	0.004	CbGpPWpGaD
Valaciclovir—Convulsion—Prednisone—Crohn's disease	0.000102	0.0022	CcSEcCtD
Valaciclovir—Hypertension—Prednisone—Crohn's disease	0.000102	0.00219	CcSEcCtD
Valaciclovir—Myalgia—Prednisone—Crohn's disease	0.0001	0.00216	CcSEcCtD
Valaciclovir—Arthralgia—Prednisone—Crohn's disease	0.0001	0.00216	CcSEcCtD
Valaciclovir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	9.94e-05	0.00215	CcSEcCtD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—GCKR—Crohn's disease	9.81e-05	0.00382	CbGpPWpGaD
Valaciclovir—Oedema—Prednisone—Crohn's disease	9.6e-05	0.00207	CcSEcCtD
Valaciclovir—Anaphylactic shock—Prednisone—Crohn's disease	9.6e-05	0.00207	CcSEcCtD
Valaciclovir—SLC6A14—SLC-mediated transmembrane transport—ALB—Crohn's disease	9.58e-05	0.00373	CbGpPWpGaD
Valaciclovir—Infection—Prednisone—Crohn's disease	9.53e-05	0.00206	CcSEcCtD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	9.53e-05	0.00371	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	9.53e-05	0.00371	CbGpPWpGaD
Valaciclovir—Nervous system disorder—Prednisone—Crohn's disease	9.41e-05	0.00203	CcSEcCtD
Valaciclovir—Tachycardia—Prednisone—Crohn's disease	9.37e-05	0.00202	CcSEcCtD
Valaciclovir—Skin disorder—Prednisone—Crohn's disease	9.32e-05	0.00201	CcSEcCtD
Valaciclovir—Anorexia—Prednisone—Crohn's disease	9.15e-05	0.00198	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Prednisone—Crohn's disease	8.74e-05	0.00189	CcSEcCtD
Valaciclovir—Insomnia—Prednisone—Crohn's disease	8.68e-05	0.00187	CcSEcCtD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	8.67e-05	0.00338	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—FADS1—Crohn's disease	8.66e-05	0.00338	CbGpPWpGaD
Valaciclovir—Paraesthesia—Prednisone—Crohn's disease	8.62e-05	0.00186	CcSEcCtD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	8.48e-05	0.0033	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	8.48e-05	0.0033	CbGpPWpGaD
Valaciclovir—Dyspepsia—Prednisone—Crohn's disease	8.45e-05	0.00182	CcSEcCtD
Valaciclovir—Decreased appetite—Prednisone—Crohn's disease	8.34e-05	0.0018	CcSEcCtD
Valaciclovir—Fatigue—Prednisone—Crohn's disease	8.27e-05	0.00179	CcSEcCtD
Valaciclovir—Constipation—Prednisone—Crohn's disease	8.21e-05	0.00177	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—GPX4—Crohn's disease	8.11e-05	0.00316	CbGpPWpGaD
Valaciclovir—Feeling abnormal—Prednisone—Crohn's disease	7.91e-05	0.00171	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Prednisone—Crohn's disease	7.85e-05	0.00169	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—GCKR—Crohn's disease	7.84e-05	0.00305	CbGpPWpGaD
Valaciclovir—Urticaria—Prednisone—Crohn's disease	7.62e-05	0.00165	CcSEcCtD
Valaciclovir—Body temperature increased—Prednisone—Crohn's disease	7.59e-05	0.00164	CcSEcCtD
Valaciclovir—Abdominal pain—Prednisone—Crohn's disease	7.59e-05	0.00164	CcSEcCtD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—GCKR—Crohn's disease	7.24e-05	0.00282	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	7.08e-05	0.00276	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	7.08e-05	0.00276	CbGpPWpGaD
Valaciclovir—Hypersensitivity—Prednisone—Crohn's disease	7.07e-05	0.00153	CcSEcCtD
Valaciclovir—Asthenia—Prednisone—Crohn's disease	6.89e-05	0.00149	CcSEcCtD
Valaciclovir—Pruritus—Prednisone—Crohn's disease	6.79e-05	0.00147	CcSEcCtD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—GCKR—Crohn's disease	6.72e-05	0.00262	CbGpPWpGaD
Valaciclovir—Diarrhoea—Prednisone—Crohn's disease	6.57e-05	0.00142	CcSEcCtD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	6.4e-05	0.00249	CbGpPWpGaD
Valaciclovir—Dizziness—Prednisone—Crohn's disease	6.35e-05	0.00137	CcSEcCtD
Valaciclovir—Vomiting—Prednisone—Crohn's disease	6.1e-05	0.00132	CcSEcCtD
Valaciclovir—Rash—Prednisone—Crohn's disease	6.05e-05	0.00131	CcSEcCtD
Valaciclovir—Dermatitis—Prednisone—Crohn's disease	6.05e-05	0.00131	CcSEcCtD
Valaciclovir—Headache—Prednisone—Crohn's disease	6.01e-05	0.0013	CcSEcCtD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—GCKR—Crohn's disease	5.97e-05	0.00233	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	5.94e-05	0.00231	CbGpPWpGaD
Valaciclovir—Nausea—Prednisone—Crohn's disease	5.7e-05	0.00123	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	5.6e-05	0.00218	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—ALB—Crohn's disease	5.32e-05	0.00207	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	5.28e-05	0.00206	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—GCKR—Crohn's disease	4.99e-05	0.00194	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	4.9e-05	0.00191	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—ALB—Crohn's disease	4.87e-05	0.0019	CbGpPWpGaD
Valaciclovir—SLC15A2—SLC-mediated transmembrane transport—ALB—Crohn's disease	4.53e-05	0.00177	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	4.41e-05	0.00172	CbGpPWpGaD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—ALB—Crohn's disease	4.21e-05	0.00164	CbGpPWpGaD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—ALB—Crohn's disease	3.74e-05	0.00146	CbGpPWpGaD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—ALB—Crohn's disease	3.12e-05	0.00122	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ALB—Crohn's disease	2.49e-05	0.000972	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—ALB—Crohn's disease	2.3e-05	0.000898	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PTGS2—Crohn's disease	2.18e-05	0.00085	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—ALB—Crohn's disease	2.14e-05	0.000833	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—ALB—Crohn's disease	1.9e-05	0.000741	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—ALB—Crohn's disease	1.59e-05	0.000618	CbGpPWpGaD
